Safety of Certolizumab Pegol in Chronic Plaque Psoriasis: Cumulative Data Over 48 Weeks' Exposure from Phase 3, Multicenter, Randomized, Placebo-Controlled Studies

Main Article Content

A Blauvelt
B Strober
R Langley
D Burge
L Pisenti
M Yassine
S Kavanagh
C Arendt
R Rolleri
K Reich

Keywords

certolizumab, psoriasis, clinical trial

Abstract

Abstract not available.

 

Disclosures: Study sponsored by UCB Pharma.

 

Copyright 2018 SKIN